Literature DB >> 12824913

Tumor formation by genetic mutations in the components of the Wnt signaling pathway.

Akira Kikuchi1.   

Abstract

The genetics of development and cancer have converged in the identification of intra- and extra-cellular signaling pathways that are aberrantly regulated in cancer, and are also central to embryonic patterning. The Wnt signaling pathway has provided an outstanding example of this. The genes for beta-catenin, APC, and Axin in the Wnt signaling pathway are often mutated in human cancers. In all such cases, the common denominator is the activation of gene transcription by beta-catenin. The resulting gene expression profile should provide a significant clue to the developmental mechanisms of cancers carrying defects in the Wnt signaling pathway. In this review, the functions of beta-catenin, APC and Axin, and the alterations of the three genes in human cancers are described.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824913     DOI: 10.1111/j.1349-7006.2003.tb01424.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  45 in total

Review 1.  Alpha-catenin: at the junction of intercellular adhesion and actin dynamics.

Authors:  Agnieszka Kobielak; Elaine Fuchs
Journal:  Nat Rev Mol Cell Biol       Date:  2004-08       Impact factor: 94.444

2.  Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide.

Authors:  Chad C Bjorklund; Wencai Ma; Zhi-Qiang Wang; R Eric Davis; Deborah J Kuhn; Steven M Kornblau; Michael Wang; Jatin J Shah; Robert Z Orlowski
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

3.  Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling.

Authors:  Manabu Kurayoshi; Hideki Yamamoto; Shunsuke Izumi; Akira Kikuchi
Journal:  Biochem J       Date:  2007-03-15       Impact factor: 3.857

Review 4.  Diseases of Wnt signaling.

Authors:  Mark L Johnson; Nalini Rajamannan
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

5.  Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation.

Authors:  Addolorata Maria Luce Coluccia; Angelo Vacca; Mireia Duñach; Luca Mologni; Sara Redaelli; Victor H Bustos; Daniela Benati; Lorenzo A Pinna; Carlo Gambacorti-Passerini
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

6.  Cytoskeletal mechanisms regulating vascular endothelial barrier function in response to acute lung injury.

Authors:  Anita Kása; Csilla Csortos; Alexander D Verin
Journal:  Tissue Barriers       Date:  2015-04-03

Review 7.  Adrenocortical carcinoma: the management of metastatic disease.

Authors:  André P Fay; Aymen Elfiky; Gabriela H Teló; Rana R McKay; Marina Kaymakcalan; Paul L Nguyen; Anand Vaidya; Daniel T Ruan; Joaquim Bellmunt; Toni K Choueiri
Journal:  Crit Rev Oncol Hematol       Date:  2014-06-04       Impact factor: 6.312

8.  Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity.

Authors:  Dexing Fang; David Hawke; Yanhua Zheng; Yan Xia; Jill Meisenhelder; Heinz Nika; Gordon B Mills; Ryuji Kobayashi; Tony Hunter; Zhimin Lu
Journal:  J Biol Chem       Date:  2007-02-07       Impact factor: 5.157

9.  Geographical mapping of a multifocal thyroid tumour using genetic alteration analysis & miRNA profiling.

Authors:  Sinéad T Aherne; Paul C Smyth; Richard J Flavin; Susan M Russell; Karen M Denning; Jing Huan Li; Simone M Guenther; John J O'Leary; Orla M Sheils
Journal:  Mol Cancer       Date:  2008-12-04       Impact factor: 27.401

10.  How genomics has informed our understanding of the pathogenesis of osteoporosis.

Authors:  Mark L Johnson; Nuria Lara; Mohamed A Kamel
Journal:  Genome Med       Date:  2009-09-07       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.